Sarantis Worldwide


Visit our group site

Sarantis Group| English

Or choose a location

Investor Relations

Through our strategy we create sustainable profitable growth and value for our shareholders.
We focus on providing prompt and accurate information to our shareholders, enhancing further their continuous positive perception and trust. 

 

IR Events

23 OCT 2025

Nine-month 2025 Trading Update

More
10 SEP 2025

H1 2025 Analysts’ and Investors’ conference call

More

2023 Annual Financial Report

2023 Download the PDF File
SAR €12.58
-1.72%
2/21/2025 CAPITALIZATION: €840,980,082.54

Our Share

The performance of our share reflects the Group’s quality, successful strategy and the positive investors’ perception of its growth potential.

More

Investor's Press

20 FEBRUARY 2025

Strong Presence of Sarantis Health & Care Division at the 16th Health Expo with clinéa, Lanes, PiC & Bio-Oil

Sarantis Health & Care Division successfully participated in the 16th Health Expo, one of Greece’s leading exhibitions in the Health and Care sector. The event, held on February 15-16 at the Megaron Athens International Conference Centre, brought together professionals and industry leaders, reaffirming the dynamic growth and significance of the health and care sector in Greece and beyond.

19 FEBRUARY 2025

Release Date of FY 2024 Annual Financial Results and Annual Financial Report & Conference Call Invitation

Sarantis Group will release its FY 2024 Annual Financial Results and Annual Financial Report, as follows: Wednesday, March 12th 2025 following Athens Exchange Market closing – Results and Report Release, which will be available at the Athens Stock Exchange website (www.

SUSTAINABILITY REPORT

CSR & Sustainability Report 2023

Download the PDF File
Presentations

Sarantis Group Investors Presentation H1 & 9Μ 2024

Download the PDF File
Change cookies consent Revoke cookies consent